Presentation is loading. Please wait.

Presentation is loading. Please wait.

Newly Developed Tissue-Engineered Material for Reconstruction of Vascular Wall Without Cell Seeding  Hiroaki Takahashi, MD, PhD, Takenori Yokota, MD,

Published byCathleen Page Modified over 5 years ago

Similar presentations

Presentation on theme: "Newly Developed Tissue-Engineered Material for Reconstruction of Vascular Wall Without Cell Seeding  Hiroaki Takahashi, MD, PhD, Takenori Yokota, MD,"— Presentation transcript:

1 Newly Developed Tissue-Engineered Material for Reconstruction of Vascular Wall Without Cell Seeding 
Hiroaki Takahashi, MD, PhD, Takenori Yokota, MD, PhD, Eiichiro Uchimura, PhD, Shigeru Miyagawa, MD, PhD, Takeyoshi Ota, MD, PhD, Kei Torikai, MD, PhD, Atsuhiro Saito, PhD, Koichiro Hirakawa, MS, Katsukiyo Kitabayashi, MD, Kenji Okada, MD, PhD, Yoshiki Sawa, MD, PhD, Yutaka Okita, MD, PhD  The Annals of Thoracic Surgery  Volume 88, Issue 4, Pages (October 2009) DOI: /j.athoracsur Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 (A) Scaffold design of polyglycolic acid (PGA)/poly-L-lactic acid (PLAA) patch (B) Intraoperative view of the tissue-engineered patch (arrow) implanted to the canine pulmonary arterial trunk. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 Macroscopic observation of the tissue-engineered patches 1 and 6 months after implantation. There were no sign of thrombus or aneurysmal formation in any animals at (A) 1 month or (B) 6 months. (C) Macroscopic findings of expanded polytetrafluoroethylene patches at 6 months showed that endothelial defects were always detected. (D) Scanning electron microscopy image (×1000) shows luminal surface of the tissue-engineered patch 1 month after implantation. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions

4 Fig 3 The upper side of the photomicrograph shows the luminal surface. Double staining with hematoxylin-eosin and Victoria blue of the tissue-engineered patches showed the presence of elastic fibers at (A) 1, (B) 2, and (C) 6 months after implantation (asterisks). Double staining with von Willebrand factor and α-smooth muscle actin showed the surface of the tissue-engineered patches were completely covered with monolayer of endothelial cells at (E) 1, (F) 2 and (G) 6 months (arrows), and α-smooth muscle actin was distributed throughout the regenerative tissue (asterisks). (D, H) In contrast, the surface of the expanded polytetrafluoroethylene patches was covered with thin layer that was not stained. The scale bar represents 300 μm. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions

5 Fig 4 (A) Scanning electron micrographs of luminal surfaces of tissue-engineered patches 3 hours after implantation showed cell adhesion and complete coverage on the scaffold surfaces. (B) Images at 3 hours after implantation showed that fibrils were directly exposed to the lumen of expanded polytetrafluoroethylene without any endothelial coverage. The scale bar represents 50 μm. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions

Download ppt "Newly Developed Tissue-Engineered Material for Reconstruction of Vascular Wall Without Cell Seeding  Hiroaki Takahashi, MD, PhD, Takenori Yokota, MD,"

Similar presentations

Prevention of Postoperative Pericardial Adhesions With a Novel Regenerative Collagen Sheet  Hiroyuki Tsukihara, MD, Shinichi Takamoto, MD, PhD, Kazuo.

Prevention of Postoperative Pericardial Adhesions With a Novel Regenerative Collagen Sheet  Hiroyuki Tsukihara, MD, Shinichi Takamoto, MD, PhD, Kazuo.
Preliminary experience with tissue engineering of a venous vascular patch by using bone marrow–derived cells and a hybrid biodegradable polymer scaffold 

Preliminary experience with tissue engineering of a venous vascular patch by using bone marrow–derived cells and a hybrid biodegradable polymer scaffold 
Use of Human Umbilical Cord Blood-Derived Progenitor Cells for Tissue-Engineered Heart Valves  Ralf Sodian, MD, Philipp Schaefermeier, PhD, Sybille Abegg-Zips,

Use of Human Umbilical Cord Blood-Derived Progenitor Cells for Tissue-Engineered Heart Valves  Ralf Sodian, MD, Philipp Schaefermeier, PhD, Sybille Abegg-Zips,
In Vitro Fabrication of a Tissue Engineered Human Cardiovascular Patch for Future Use in Cardiovascular Surgery  Chao Yang, MD, Ralf Sodian, MD, Ping.

In Vitro Fabrication of a Tissue Engineered Human Cardiovascular Patch for Future Use in Cardiovascular Surgery  Chao Yang, MD, Ralf Sodian, MD, Ping.
Tissue Engineering of Autologous Human Heart Valves Using Cryopreserved Vascular Umbilical Cord Cells  Ralf Sodian, MD, Cora Lueders, PhD, Liv Kraemer,

Tissue Engineering of Autologous Human Heart Valves Using Cryopreserved Vascular Umbilical Cord Cells  Ralf Sodian, MD, Cora Lueders, PhD, Liv Kraemer,
Bioengineered vascular access maintains structural integrity in response to arteriovenous flow and repeated needle puncture  Bryan W. Tillman, MD, PhD,

Bioengineered vascular access maintains structural integrity in response to arteriovenous flow and repeated needle puncture  Bryan W. Tillman, MD, PhD,
New engineering treatment of bovine pericardium confers outstanding resistance to calcification in mitral and pulmonary implantations in a juvenile sheep.

New engineering treatment of bovine pericardium confers outstanding resistance to calcification in mitral and pulmonary implantations in a juvenile sheep.
Aquilino Hurlé, MD, PhD, Damián Sánchez-Quintana, MD, PhD, Siew Y

Aquilino Hurlé, MD, PhD, Damián Sánchez-Quintana, MD, PhD, Siew Y
Biodegradable polymer with collagen microsponge serves as a new bioengineered cardiovascular prosthesis  Shigemitsu Iwai, MD, Yoshiki Sawa, MD, Hajime.

Biodegradable polymer with collagen microsponge serves as a new bioengineered cardiovascular prosthesis  Shigemitsu Iwai, MD, Yoshiki Sawa, MD, Hajime.
Fariba Chalajour, MD, Laura A

Fariba Chalajour, MD, Laura A
Reconstruction of pulmonary artery with porcine small intestinal submucosa in a lamb surgical model: Viability and growth potential  Lorenzo Boni, MD,

Reconstruction of pulmonary artery with porcine small intestinal submucosa in a lamb surgical model: Viability and growth potential  Lorenzo Boni, MD,
Mesothelium regeneration on acellular bovine pericardia loaded with an angiogenic agent (ginsenoside Rg1) successfully reduces postsurgical pericardial.

Mesothelium regeneration on acellular bovine pericardia loaded with an angiogenic agent (ginsenoside Rg1) successfully reduces postsurgical pericardial.
Perforation of the Valsalva Sinus After Implantation of Medtronic Freestyle Aortic Bioprosthesis  Nobuchika Ozaki, MD, Yutaka Hino, MD, Yuji Hanafusa,

Perforation of the Valsalva Sinus After Implantation of Medtronic Freestyle Aortic Bioprosthesis  Nobuchika Ozaki, MD, Yutaka Hino, MD, Yuji Hanafusa,
Libman-Sacks Endocarditis Due to Systemic Lupus Erythematosus Activation After Mitral Valve Plasty  Takaaki Samura, MD, Koichi Toda, MD, PhD, Daisuke.

Libman-Sacks Endocarditis Due to Systemic Lupus Erythematosus Activation After Mitral Valve Plasty  Takaaki Samura, MD, Koichi Toda, MD, PhD, Daisuke.
Vascular anastomoses with laser energy

Vascular anastomoses with laser energy
Novel Tissue-Engineered Biodegradable Material for Reconstruction of Vascular Wall  Shigemitsu Iwai, MD, Yoshiki Sawa, MD, Satoshi Taketani, MD, Kei Torikai,

Novel Tissue-Engineered Biodegradable Material for Reconstruction of Vascular Wall  Shigemitsu Iwai, MD, Yoshiki Sawa, MD, Satoshi Taketani, MD, Kei Torikai,
Tissue-engineered stent-graft integrates with aortic wall by recruiting host tissue into graft scaffold  Mugiho Takeuchi, MD, Toru Kuratani, MD, PhD,

Tissue-engineered stent-graft integrates with aortic wall by recruiting host tissue into graft scaffold  Mugiho Takeuchi, MD, Toru Kuratani, MD, PhD,
Preliminary experience with tissue engineering of a venous vascular patch by using bone marrow–derived cells and a hybrid biodegradable polymer scaffold 

Preliminary experience with tissue engineering of a venous vascular patch by using bone marrow–derived cells and a hybrid biodegradable polymer scaffold 
Mid-Term Clinical Results Using a Tissue-Engineered Pulmonary Valve to Reconstruct the Right Ventricular Outflow Tract During the Ross Procedure  Pascal.

Mid-Term Clinical Results Using a Tissue-Engineered Pulmonary Valve to Reconstruct the Right Ventricular Outflow Tract During the Ross Procedure  Pascal.
Lucas P. Neff, MD, Bryan W. Tillman, MD, PhD, Saami K

Lucas P. Neff, MD, Bryan W. Tillman, MD, PhD, Saami K

Similar presentations

Ads by Google